The conceptualization of ‘Key Evidence Leaders’ from ‘Opinion Leaders’: A review also applicable in ophthalmology

J. Fernández , F. Ribeiro , H.B. Dick , T. Kohnen , C. Rocha-de-Lossada , M. Rodríguez-Vallejo
{"title":"The conceptualization of ‘Key Evidence Leaders’ from ‘Opinion Leaders’: A review also applicable in ophthalmology","authors":"J. Fernández ,&nbsp;F. Ribeiro ,&nbsp;H.B. Dick ,&nbsp;T. Kohnen ,&nbsp;C. Rocha-de-Lossada ,&nbsp;M. Rodríguez-Vallejo","doi":"10.1016/j.oftale.2025.07.016","DOIUrl":null,"url":null,"abstract":"<div><div>The collaboration of ophthalmologists with the industry, in their role as opinion leaders (OLs) who interpret, modify, and disseminate information to professional networks, is susceptible to bias. This review explores the critical role of OLs in the healthcare industry and their evolution into Key Evidence Leaders (KELs), emphasizing the importance of differentiating KELs from traditional OLs to promote evidence-based practices and maintain research integrity in healthcare. OLs often rely on their reputation and experience, which can make them susceptible to industry biases, particularly when financial incentives are involved. The concept of KELs marks a significant evolution from traditional OLs. Unlike OLs, KELs base their influence on expertise in clinical evidence and research, rather than personal experience or industry affiliations. KELs possess strong analytical skills, engage in interdisciplinary collaboration, and emphasize transparency and unbiased dissemination of information. The emergence of KELs represents a significant shift towards evidence-based leadership in healthcare. Differentiating KELs from traditional OLs is crucial for ensuring that the messages received by healthcare professionals are less biased. By supporting KELs who prioritize patient-centered evidence, the industry can enhance trust in the application of medical devices and drugs.</div></div>","PeriodicalId":93886,"journal":{"name":"Archivos de la Sociedad Espanola de Oftalmologia","volume":"100 10","pages":"Pages 618-624"},"PeriodicalIF":0.0000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archivos de la Sociedad Espanola de Oftalmologia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S217357942500132X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The collaboration of ophthalmologists with the industry, in their role as opinion leaders (OLs) who interpret, modify, and disseminate information to professional networks, is susceptible to bias. This review explores the critical role of OLs in the healthcare industry and their evolution into Key Evidence Leaders (KELs), emphasizing the importance of differentiating KELs from traditional OLs to promote evidence-based practices and maintain research integrity in healthcare. OLs often rely on their reputation and experience, which can make them susceptible to industry biases, particularly when financial incentives are involved. The concept of KELs marks a significant evolution from traditional OLs. Unlike OLs, KELs base their influence on expertise in clinical evidence and research, rather than personal experience or industry affiliations. KELs possess strong analytical skills, engage in interdisciplinary collaboration, and emphasize transparency and unbiased dissemination of information. The emergence of KELs represents a significant shift towards evidence-based leadership in healthcare. Differentiating KELs from traditional OLs is crucial for ensuring that the messages received by healthcare professionals are less biased. By supporting KELs who prioritize patient-centered evidence, the industry can enhance trust in the application of medical devices and drugs.
从“意见领袖”到“关键证据领袖”的概念:也适用于眼科的综述。
眼科医生与业界的合作,作为意见领袖(ol)的角色,他们解释、修改并向专业网络传播信息,容易产生偏见。本文探讨了关键证据领导者在医疗保健行业中的关键作用及其向关键证据领导者的演变,强调了将关键证据领导者与传统的关键证据领导者区分开来,以促进循证实践和保持医疗保健研究完整性的重要性。OLs通常依赖于他们的声誉和经验,这可能使他们容易受到行业偏见的影响,特别是在涉及财政激励的情况下。kel的概念标志着传统ol的重大演变。与ol不同,kol的影响力基于临床证据和研究方面的专业知识,而不是个人经验或行业关系。知识分子具有较强的分析能力,从事跨学科合作,并强调透明度和公正的信息传播。KELs的出现代表了医疗保健领域向循证领导的重大转变。区分kell与传统ol对于确保医疗保健专业人员收到的信息较少偏见至关重要。通过支持优先考虑以患者为中心的证据的kel,该行业可以增强对医疗设备和药物应用的信任。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信